CIC expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.642399998809E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.65389996037635E-09 |
Normal-vs-Stage2 |
1.617080E-03 |
Normal-vs-Stage3 |
1.406560E-04 |
Normal-vs-Stage4 |
8.377400E-03 |
Stage1-vs-Stage2 |
6.860000E-01 |
Stage1-vs-Stage3 |
1.425000E-01 |
Stage1-vs-Stage4 |
9.944800E-03 |
Stage2-vs-Stage3 |
5.474000E-01 |
Stage2-vs-Stage4 |
2.023000E-01 |
Stage3-vs-Stage4 |
3.222600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.87619999986377E-07 |
Normal-vs-AfricanAmerican |
1.53049999995769E-06 |
Normal-vs-Asian |
5.064200E-03 |
Caucasian-vs-AfricanAmerican |
9.740100E-03 |
Caucasian-vs-Asian |
4.752000E-01 |
AfricanAmerican-vs-Asian |
4.132200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.51120000002614E-06 |
Normal-vs-Female |
6.41300001991141E-09 |
Male-vs-Female |
5.155800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.356100E-02 |
Normal-vs-Age(41-60Yrs) |
2.16600000157996E-08 |
Normal-vs-Age(61-80Yrs) |
1.40140000004507E-06 |
Normal-vs-Age(81-100Yrs) |
2.177800E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.123000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.659400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.606400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.432600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.494440E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.200200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.64235292032799E-12 |
Normal-vs-Grade 2 |
4.45660000014669E-08 |
Normal-vs-Grade 3 |
7.70230000000094E-05 |
Normal-vs-Grade 4 |
4.812700E-04 |
Grade 1-vs-Grade 2 |
3.97100000004702E-06 |
Grade 1-vs-Grade 3 |
2.30609999984921E-08 |
Grade 1-vs-Grade 4 |
1.19740000137369E-08 |
Grade 2-vs-Grade 3 |
7.674000E-02 |
Grade 2-vs-Grade 4 |
1.931820E-01 |
Grade 3-vs-Grade 4 |
8.797800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.12390000037455E-07 |
Normal-vs-ccB subtype |
4.29360000000489E-05 |
ccA subtype-vs-ccB subtype |
5.110400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.64856000000047E-05 |
Normal-vs-N1 |
2.042400E-02 |
N0-vs-N1 |
9.557000E-01 |
|
|